Defunct Company
Total Trials
2
As Lead Sponsor
1
As Collaborator
Total Enrollment
384
NCT00689065
Safety Study of CALAA-01 to Treat Solid Tumor Cancers
Phase: Phase 1
Role: Lead Sponsor
Start: May 31, 2008
Completion: Sep 30, 2012
NCT01762514
A Phase II Clinical Trial on Comparison of Effectiveness and Safeness of Different Amifostine Regimens
Phase: Phase 2
Role: Collaborator
Start: Jan 31, 2013
Completion: Dec 31, 2019